『Launch of gastrointestinal motility improving agent ‘Gaspren CR Tablet’』
KyungDong Pharm Co., Ltd. launches gastrointestinal motility improver ‘Gaspren CR Tablet’ on July 27, 2020.
This drug is prescribed for digestive symptoms such as heartburn, nausea, and vomiting in patients with functional dyspepsia.
It is designed with a two-layer structure (immediate-release layer + sustained-release layer), and its efficacy lasts for 24 hours when administered once a day.
In particular, the newly released Gasprene CR tablets, unlike the existing Gasprene tablets, are to be taken once a day.
It has the advantage of high medication compliance when used in combination with other once-daily medications.
In addition, it has good compatibility with PPI and improves symptoms of delayed gastric emptying compared to PPI alone.
‘Gaspren CR Tablet’, which has these various advantages, is widely used by internists, general practitioners, etc.
It is expected to be an item that will lead to increased sales of KyungDong Pharm in various medical departments.
♤ Product Information ♤
|
Product Name |
Gasprene CR tablets |
|
Ingredient content |
Mosapride 15mg (immediate release layer 4mg/sustained release layer 11mg) |
|
Indications |
Digestive symptoms due to functional dyspepsia (heartburn, nausea, vomiting) |
|
Dosage and usage |
Adults: Mosapride citrate anhydrous, 15 mg per day. Administer orally once a day. This medicine should be taken on an empty stomach, avoiding meals. Since this medicine is a sustained-release preparation, it must be crushed, pulverized, or Do not chew and swallow the tablet whole. |
|
Packaging unit |
30T/bottle, 300T/bottle |
※ Please refer to the product manual for other details such as precautions for use.